Aurinia Pharmaceuticals AUPH Other Operating Income Expense Net
Other Operating Income Expense Net at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's other operating income expense net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's other operating income expense net?
- Aurinia Pharmaceuticals (AUPH) reported other operating income expense net of -$279K in Q1 2026.
- How has Aurinia Pharmaceuticals's other operating income expense net changed year-over-year?
- Aurinia Pharmaceuticals's other operating income expense net increased by 93.7% year-over-year, from -$4.43M to -$279K.
- What is the long-term trend for Aurinia Pharmaceuticals's other operating income expense net?
- Over 2 years (2022 to 2024), Aurinia Pharmaceuticals's other operating income expense net has grown at a 68.9% compound annual growth rate (CAGR), from $1.52M to $4.35M.